Wu, Yu-jie
Deng, Bo
Wang, Si-bo
Qiao, Rui
Zhang, Xi-wen
Lu, Yuan
Wang, Li
Gu, Shun-zhong
Zhang, Yu-qing
Li, Kai-qiao
Yu, Zong-liang
Wu, Li-xing
Zhao, Sheng-biao
Zhou, Shuang-lin
Yang, Yang
Wang, Lian-sheng
Article History
Accepted: 17 July 2023
First Online: 1 September 2023
Compliance with ethical standards
:
: The authors declare no competing interests. The authors wish to acknowledge Tasly Pharmaceutical Group Co., Ltd. for providing financial support and relevant information about CDDP. As this is an investigator-initiated trial, the authors designed and conducted the study. Data collection has been managed by independent data recorders at each participating center where the data originated. The funding body does not interfere in the analysis and interpretation of the data.
: Confidentiality in the collection of personal information is protected in accordance with the Ethical Guidelines for Medical and Health Research Involving Human Subjects in China.